~12 spots leftby Apr 2026

Diabetes Self-Management Program for Type 2 Diabetes

(MenD 2 Trial)

Recruiting in Palo Alto (17 mi)
JH
Overseen byJaclynn Hawkins, PhD
Age: 18+
Sex: Male
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Michigan
No Placebo Group

Trial Summary

What is the purpose of this trial?

The Michigan Men's Diabetes Project 2 (MenD 2) is an 18-month pilot randomized clinical trial. We are looking to recruit 60 Black men with type 2 diabetes (need to have diagnosis for at least 6 months) that are over the age of 21. Interested participants need to be under the care of a physician for their diabetes, have access to reliable transportation for study activities, and be willing to participate in 4 health assessments where they will get their A1C, blood pressure, height, and weight measured and they will complete a survey. All participants will receive 10 hours of diabetes self-management education with a Certified Diabetes Care and Education Specialist. Participants randomized to the intervention arm will also be offered 6 months of monthly diabetes self-management support (DSMS) sessions with trained Peer Leaders who are also Black men with type 2 diabetes. After the 6 months of support, this group will transition into 6 months of ongoing support where they can continue DSMS and/or other diabetes related initiatives that are important to the group and chosen by the group. Due to the COVID-19 pandemic, DSME and DSMS sessions will likely be held via Zoom, ongoing support sessions have potential to be in person. The 4 health assessments will take place at baseline, 3-months, 9-months, and 15-months.

Research Team

JH

Jaclynn Hawkins, PhD

Principal Investigator

University of Michigan, School of Social Work

Eligibility Criteria

The Michigan Men's Diabetes Project 2 is seeking Black men over the age of 21 with type 2 diabetes diagnosed for at least six months. Participants must be under a doctor's care, have reliable transportation, and an A1c level of 8% or higher. They should be willing to attend group sessions and complete health assessments throughout the study.

Inclusion Criteria

I am being treated for diabetes by a doctor.
I am a Black/African American male, 21 or older, diagnosed with type 2 diabetes for six months.
I am willing to participate in group sessions.
See 1 more

Exclusion Criteria

Your A1c level (a measure of blood sugar control) is less than 8%.

Treatment Details

Interventions

  • Diabetes Self-Management Education (NA)
  • Peer Led Diabetes Self-Management Support (NA)
Trial OverviewThis trial tests whether peer-led diabetes self-management support (DSMS) improves health outcomes in addition to standard diabetes education. Half will receive DSMS from trained peers for six months, followed by ongoing group-chosen support activities; all get ten hours of education from a specialist.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Peer led diabetes self-management support (PLDSMS)Experimental Treatment2 Interventions
Participants in the PLDSMS arm will receive 10 hours of diabetes self-management education (DSME) with a certified diabetes care and education specialist. This group will then transition into monthly 90-minute diabetes self-management support (DSMS) with trained peer leaders for 6 months. After the DSMS sessions, the group will transition into 6 months of ongoing support and will be encouraged to continue DSMS through initiatives that are important to them.
Group II: Control GroupActive Control1 Intervention
Participants in the control group will receive 10 hours of diabetes self-management education (DSME) with a certified diabetes care and education specialist.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

Marschall S. Runge

University of Michigan

Chief Executive Officer since 2015

MD, PhD

Karen McConnell profile image

Karen McConnell

University of Michigan

Chief Medical Officer since 2020

MD